Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Takeshi Morimoto
With
University of the Ryukyus
Prevalence of type 2 diabetes in Asia seems to be almost epidemic and establishment of preventive strategy against macrovascular as well as microvascular diseases are warranted because of higher cardiovascular risk in diabetic patients even without history of atherosclerotic cardiovascular diseases. Benefit of lowering low density lipoprotein (LDL) cholesterol down to 70 mg/ml in Caucasian patients with coronary artery disease (CAD) has been well established but not in Asian patients with lower risk of myocardial infarction and higher stroke risk. Intensive lowering blood pressure for cardiovascular outcome in diabetic patients and patients with CAD has been recommended in several guidelines without firm evidence. Risk and benefit of intensive blood pressure and LDL control should be evaluated in Japanese diabetic CAD patients by pragmatic randomized controlled trial.
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Type 2 diabetic patients with coronary artery disease and history of acute coronary syndrome
Patients whose blood pressure and LDL cholesterol levels are above values recommended by the current guideline
You may not be if
Patients who have active malignant tumor
Patients who are on hemodialysis due to end stage kidney disease
Patients whom statins are contraindicated
Patients who had acute coronary syndrome or stroke within 3 months
Patients who are pregnant or on breast feeding
Patients whose physicians deem that attending this trial is contraindicated or inappropriate
Clareo Health | Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
